G Meloni|T Meloni - JoVE Visualize

Showing results (251-260 of 283) with videos related to

Pageof 29

Sort By:

Annals of Hematology|April 1, 2014

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)R Willemze, S Suciu, P Muus, et al.

Bone Marrow Transplantation|July 1, 1996

Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.

Cancer|September 15, 1980

Discontinuing therapy in childhood acute lymphocytic leukemia. A multicentric survey in ItalyF Mandelli, S Amadori, A C Rajnoldi, et al.

Journal of AIDS & Clinical Research|November 13, 2018

Predictors of Mortality in a Clinic Cohort of HIV-1 Infected Children Initiated on Antiretroviral Therapy in Jos, NigeriaAugustine O Ebonyi, Stephen Oguche, Seema T Meloni, et al.

Current HIV Research|May 20, 2015

Mother-to-Child Transmission Outcomes of HIV-Exposed Infants Followed Up in Jos North-Central NigeriaAtiene S Sagay, Augustine O Ebonyi, Seema T Meloni, et al.

Optics Express|July 21, 2015

Sub-Nyquist field trial using time frequency packed DP-QPSK super-channel within fixed ITU-T gridL Potì, G Meloni, G Berrettini, et al.

Blood|September 25, 1999

Therapy of molecular relapse in acute promyelocytic leukemiaF Lo Coco, D Diverio, G Avvisati, et al.

Journal of Biological Regulators and Homeostatic Agents|April 23, 2014

Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgarisM L Roberti, L Ricottini, A Capponi, et al.

HIV Medicine|March 4, 2014

Patients who present late to HIV care and associated risk factors in NigeriaP A Agaba, S T Meloni, H M Sule, et al.

Plos One|September 27, 2013

Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in NigeriaHolly E Rawizza, Beth Chaplin, Seema T Meloni, et al.

Pageof 29

Showing results (251-260 of 283) with videos related to

Sort By:

Pageof 29

Annals of Hematology|April 1, 2014

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)R Willemze, S Suciu, P Muus, et al.

Bone Marrow Transplantation|July 1, 1996

Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.

Cancer|September 15, 1980

Discontinuing therapy in childhood acute lymphocytic leukemia. A multicentric survey in ItalyF Mandelli, S Amadori, A C Rajnoldi, et al.

Journal of AIDS & Clinical Research|November 13, 2018

Predictors of Mortality in a Clinic Cohort of HIV-1 Infected Children Initiated on Antiretroviral Therapy in Jos, NigeriaAugustine O Ebonyi, Stephen Oguche, Seema T Meloni, et al.

Current HIV Research|May 20, 2015

Mother-to-Child Transmission Outcomes of HIV-Exposed Infants Followed Up in Jos North-Central NigeriaAtiene S Sagay, Augustine O Ebonyi, Seema T Meloni, et al.

Optics Express|July 21, 2015

Sub-Nyquist field trial using time frequency packed DP-QPSK super-channel within fixed ITU-T gridL Potì, G Meloni, G Berrettini, et al.

Blood|September 25, 1999

Therapy of molecular relapse in acute promyelocytic leukemiaF Lo Coco, D Diverio, G Avvisati, et al.

Journal of Biological Regulators and Homeostatic Agents|April 23, 2014

Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgarisM L Roberti, L Ricottini, A Capponi, et al.

HIV Medicine|March 4, 2014

Patients who present late to HIV care and associated risk factors in NigeriaP A Agaba, S T Meloni, H M Sule, et al.

Plos One|September 27, 2013

Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in NigeriaHolly E Rawizza, Beth Chaplin, Seema T Meloni, et al.

Pageof 29